Upsher-Smith

A Trusted U.S. Pharmaceutical Company
We strive to improve the health and lives of patients by manufacturing and marketing brand and generic pharmaceutical products across multiple therapeutic areas. Our work is always backed by our attentive level of service, strong industry relationships and dedication to uninterrupted supply.

Upsher-Smith Products
Upsher-Smith strives to manufacture high-quality products that aim to improve the health and lives of patients. Our principal offerings today include several brand medications that help patients living with migraine headaches and seizure disorders, as well as a wide variety of generics.

About Upsher-Smith
Our story began in 1919, when English-born pharmacist and chemist Frederick Alfred Upsher Smith started a company to refine digitalis. Working from a laboratory in downtown Minneapolis, his innovations helped thousands of people struggling with cardiac disease.

More than 100 years later, we at Upsher-Smith Laboratories, LLC are still carrying out our original founder’s commitment to help improve the health and lives of patients. We offer a broad array of generic and branded medications, and our portfolio continues to grow. We know that our customers have many options to choose from in the marketplace, but we believe they repeatedly choose us because we go above and beyond—striving for uninterrupted supply, quick delivery and in-depth account and patient knowledge.

Learn more about our history

Fast Facts About Upsher-Smith

• We’ve been in business for 105 years

• Unlike many American pharma companies, we actually manufacture in the U.S.

• We have 450+ employees

• Most of our office positions offer a hybrid work arrangement

• We have 4 Employee Resource Groups

• Volunteerism is encouraged, and we even grant time off to do it

• We manufacture, pack, or distribute 1.9 B doses each year

• Our generic drugs come in the form of tablets, gels, capsules, topical powders, oral (drinkable) suspensions and ophthalmic solutions (eye drops) and they help treat a variety of medical conditions

Sawai Pharmaceutical Co., Ltd
Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that has strived to deliver quality, affordable generic medications for nearly a century. In June 2017, Upsher-Smith was acquired by Sawai Pharmaceutical Co., Ltd., a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.

Upsher-Smith and Sawai share a strikingly similar family history and hold many of the same cherished goals and values—most importantly, the philosophy of always putting patients first. Upsher-Smith will continue to do those things we feel we do best—provide a consistent supply of quality, affordable medications, and invest in our historically strong industry relationships. And as we further organize into one global company with Sawai, we will begin to benefit from Sawai’s extensive resources and management focus.

Ultimately, we believe our acquisition by Sawai represents a tremendous opportunity to leverage each other for growth worldwide as we embark together on an exciting new chapter in generics.